TerminatedPhase 2NCT00072280
Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
Studying Fibrosarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Mignon Loh, MDUniversity of California, San Francisco
- Intervention
- dactinomycin(biological)
- Enrollment
- 7 target
- Eligibility
- 2 years · All sexes
- Timeline
- 2004 – 2008
Study locations (30)
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Southern California Permanente Medical Group, Downey, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, United States
- Jonathan Jaques Children's Cancer Center at Miller Children's Hospital, Long Beach, California, United States
- Kaiser Permanente Medical Center - Oakland, Sacramento, California, United States
- UCSF Comprehensive Cancer Center, San Francisco, California, United States
- Stanford Comprehensive Cancer Center - Stanford, Stanford, California, United States
- Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, Farmington, Connecticut, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C., District of Columbia, United States
- Lee Cancer Care of Lee Memorial Health System, Fort Myers, Florida, United States
- University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
- Sacred Heart Cancer Center at Sacred Heart Hospital, Pensacola, Florida, United States
- All Children's Hospital, St. Petersburg, Florida, United States
- St. Joseph's Cancer Institute at St. Joseph's Hospital, Tampa, Florida, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00072280 on ClinicalTrials.govOther trials for Fibrosarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT05566795DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)Day One Biopharmaceuticals, Inc.
- ACTIVE NOT RECRUITINGPHASE2NCT03834961Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute LeukemiaChildren's Oncology Group